Výsledky vyhledávání - "Marleen Zuurveld"

Akademický článek

In vitro reversal of direct factor Xa inhibitors: Direct comparison of andexanet alfa and prothrombin complex concentrates Cofact and Beriplex/Kcentra

Autor: Herm Jan M. Brinkman, Marleen Zuurveld, Joost C. M. Meijers

Publikováno v: Research and Practice in Thrombosis and Haemostasis, Vol 6, Iss 5, Pp n/a-n/a (2022)

Abstract Background Both andexanet alfa and four‐factor prothrombin complex concentrate (4F‐PCC) are clinically applied reversal agents for direct factor Xa inhibitors (FXaIs) in emergency situations. Controversy exists whether 4F‐PCC is as eff

Externí odkaz: https://doaj.org/article/583703f2c07d49769b9fd32973e174b0

Zobrazit plný text záznamu

Akademický článek

Emergencies on direct oral anticoagulants: Management, outcomes, and laboratory effects of prothrombin complex concentrate

Autor: Roisin Bavalia, Rahat Abdoellakhan, Herm Jan M. Brinkman, Marjolein P. A. Brekelmans, Eva N. Hamulyák, Marleen Zuurveld, Barbara A. Hutten, Peter E. Westerweel, Renske H. Olie, Hugo ten Cate, Marieke Kruip, Saskia Middeldorp, Karina Meijer, Michiel Coppens

Publikováno v: Research and Practice in Thrombosis and Haemostasis, Vol 4, Iss 4, Pp 569-581 (2020)

Abstract Background In the initial absence of specific reversal agents for factor Xa inhibitors (FXa‐Is), prothrombin complex concentrate (PCC) as a hemostatic agent has been recommended by guidelines. Since 2017, idarucizumab has been registered f

Externí odkaz: https://doaj.org/article/c345245df8e24ff4a9568e4a78c0f1cb

Zobrazit plný text záznamu

Akademický článek

Reversing direct factor Xa or thrombin inhibitors: Factor V addition to prothrombin complex concentrate is beneficial in vitro

Autor: Herm Jan M. Brinkman, Frauke Swieringa, Marleen Zuurveld, Alicia Veninga, Sanne L. N. Brouns, Johan W. M. Heemskerk, Joost C. M. Meijers

Publikováno v: Research and Practice in Thrombosis and Haemostasis, Vol 6, Iss 3, Pp n/a-n/a (2022)

Abstract Background Prothrombin complex concentrate (PCC) is a human plasma‐derived mixture of partially purified vitamin K‐dependent coagulation factors (VKCF). Current therapeutic indication is treatment and perioperative prophylaxis of bleedin

Externí odkaz: https://doaj.org/article/686b1ea5e4d14d848f33507bf2dc4b31

Zobrazit plný text záznamu

Emergencies on direct oral anticoagulants

Autor: Herm Jan M. Brinkman, Saskia Middeldorp, Barbara A. Hutten, Marjolein P. A. Brekelmans, Michiel Coppens, Marieke J. H. A. Kruip, Eva N. Hamulyák, Rahat A. Abdoellakhan, Karina Meijer, Peter E. Westerweel, Hugo ten Cate, Renske H. Olie, Marleen Zuurveld, Roisin Bavalia

Publikováno v: Research and practice in thrombosis and haemostasis, 4(4), 569-581. Wiley
Research and Practice in Thrombosis and Haemostasis, 4(4), 569-581. Wiley-Blackwell Publishing Ltd
Research and Practice in Thrombosis and Haemostasis
Research and Practice in Thrombosis and Haemostasis, Vol 4, Iss 4, Pp 569-581 (2020)
Research and practice in thrombosis and haemostasis, 4(4), 569-581. Wiley-Blackwell Publishing Ltd

Background In the initial absence of specific reversal agents for factor Xa inhibitors (FXa-Is), prothrombin complex concentrate (PCC) as a hemostatic agent has been recommended by guidelines. Since 2017, idarucizumab has been registered for dabigatr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52f0368b4df92c7256a467c04bad2999
https://hdl.handle.net/11370/90876bf2-f7b8-4774-a8b9-77266e16545a

Zobrazit plný text záznamu

Hemostatic profile under fluid resuscitation during rivaroxaban anticoagulation: an in vitro survey

Autor: Marleen Zuurveld, Joost C. M. Meijers, Mikko Manninen, Herm Jan M. Brinkman, Riitta Lassila, Tuukka Helin

Publikováno v: Transfusion. 58:3014-3026

BACKGROUND: Uncontrollable bleeding is the leading cause of death in traumatically injured patients. The extent to which direct factor Xa inhibitors interfere with the applied resuscitation measures is presently unknown. STUDY DESIGN AND METHODS: In

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::20a9fe454a4ac6e2376bc8e4fbfc5a64
https://doi.org/10.1111/trf.14933

Zobrazit plný text záznamu

Hemostatic profile under fluid resuscitation during rivaroxaban anticoagulation: an in vitro survey

Autor: Tuukka A, Helin, Marleen, Zuurveld, Mikko, Manninen, Joost C M, Meijers, Riitta, Lassila, Herm Jan M, Brinkman

Publikováno v: Transfusion. 58(12):3014-3026

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::72be26d243bd92b43fd7d5dfd9bd5d99
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85055281477&origin=inward

Zobrazit plný text záznamu

Abnormal coagulation and enhanced fibrinolysis due to lysinuric protein intolerance associates with bleeds and renal impairment

Autor: Hanna H. Pitkänen, Wil F. Kopatz, Joost C. M. Meijers, M. Pikta, Herm Jan M. Brinkman, Marleen Zuurveld, Laura Tanner, Harri Niinikoski, Riitta Lassila, Mari Kärki, Kirsti Näntö-Salonen

Publikováno v: Haemophilia, 24(5), e312-e321. Wiley-Blackwell

Introduction: Lysinuric protein intolerance (LPI), a rare autosomal recessive transport disorder of cationic amino acids lysine, arginine and ornithine, affects intestines, lungs, liver and kidneys. LPI patients may display potentially life-threateni

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbe5b6d6ce86ecb9171db859d12f1ff1
http://hdl.handle.net/10138/308858

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání